Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00026754 · ClinicalTrials.gov registry record

Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
19,522
Enrollment target

NCT00026754: Completed study, sponsored by National Cancer Institute (NCI).

NCT00026754 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 19,522 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00026754 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
19,522 participants
Enrollment target

Study Summary

The purpose of this protocol is to provide patients with adequate informed consent to understand that screening tests with minimal health risk will be performed to evaluate their eligibility for a research study. The protocol makes it clear that patients initial visit to the intramural clinical program may include screening studies that are not medically necessary for disease management, but are done purely for research purposes. Patients with a known or suspected diagnosis of cancer, HIV infection, skin disorder or immunodeficiency who are being considered for enrollment in a National Cancer Institute intramural clinical research protocol will participate in this consent protocol. It informs patients of screening tests and procedures involving minimal risk that are done for research purposes only, including blood tests, electrocardiogram, standard X-rays (e.g., chest X-ray), bone films, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine studies. It explains that other eligibility screens that are more invasive and involve greater risk, such as a biopsy, will require separate consent. ...

Trial Details

FieldValue
Enrollment Target 19,522 participants
Start Date 2004-01-14
Est. Completion 2024-11-29

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00026754

The ClinicalTrials.gov registry entry for NCT00026754 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19,522 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00026754 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00026754 about?

NCT00026754 is a clinical study titled "Eligibility Screening for the NIH Intramural Research Program Clinical Protocols". The purpose of this protocol is to provide patients with adequate informed consent to understand that screening tests with minimal health risk will be performed to evaluate their eligibility for a research study. The protocol makes it clear that patients initial visit to the intramural clinical prog...

What is the current status of trial NCT00026754?

This trial is currently completed. The enrollment target is 19,522 participants. The study started on 2004-01-14. Estimated completion is 2024-11-29.

Who is sponsoring clinical trial NCT00026754?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.